Valuation Verastem, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-04 EDT			5-day change	1st Jan Change
5.810 ^USD	+2.11%		-6.74%	-24.74%

07-28	Verastem Oncology Doses First Patient in TARGET-D 203 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Colorectal Cancer	CI
07-22	Verastem Oncology Doses First Patient in Target-D 202 Phase 2 Registration-Directed Trial of Vs-7375 for Kras G12d-Mutated Advanced Non-Small Cell Lung Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	373.5	84.56	205.7	230.1	595.8	511	-	-
Change	-	-77.36%	143.23%	11.87%	158.95%	-14.24%	-	-
Enterprise Value (EV) ¹	373.5	84.56	205.7	230.1	595.8	346	301.4	414.2
Change	-	-77.36%	143.23%	11.87%	158.95%	-41.93%	-12.89%	37.43%
P/E	-5x	-1.06x	-2.06x	-1.41x	-2.56x	-3.67x	-5.18x	-7.71x
PBR	-	-	-	-	-	-	-	-
PEG	-	0.14x	0.2x	0.19x	0.1x	0.1x	0.2x	0.2x
Capitalization / Revenue	182x	32.6x	-	23x	19.3x	5.02x	2.87x	1.94x
EV / Revenue	182x	32.6x	-	23x	19.3x	3.4x	1.69x	1.57x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-6.08x	-1.16x	-2.23x	-2x	-3.5x	-2x	-2.14x	-4.33x
EV / FCF	-	-	-2.38x	-2.2x	-4.05x	-2.12x	-2.25x	-5.05x
FCF Yield	-	-	-42%	-45.5%	-24.7%	-47.1%	-44.4%	-19.8%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-4.92	-4.56	-3.96	-3.66	-3.02	-1.583	-1.121	-0.7533
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2.053	2.596	-	10	30.91	101.9	178.3	263
EBITDA	-	-	-	-114.9	-	-	-	-
EBIT ¹	-61.41	-72.94	-92.08	-115	-170.1	-173.4	-140.7	-95.66
Net income ¹	-71.2	-73.81	-87.37	-130.6	-209.5	-165.5	-142.1	-100.4
Net Debt ¹	-	-	-	-	-	-165	-209.6	-96.8
Reference price ²	24.600	4.830	8.140	5.170	7.720	5.810	5.810	5.810
Nbr of stocks (in thousands)	15,182	17,508	25,268	44,507	77,182	87,874	-	-
Announcement Date	3/28/22	3/14/23	3/14/24	3/20/25	3/4/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERASTEM, INC.	-3.59x	3.29x	-	-	500M
WUXI APPTEC CO., LTD.	17.93x	5.93x	12.15x	1.71%	56.7B
ARGENX SE	30.64x	7.55x	23.21x	0.05%	51.97B
BIONTECH SE	-18.24x	4.35x	-7.62x	-.--%	23.33B
INSMED INCORPORATED	-37.99x	12.2x	-35.93x	-.--%	21.34B
GENMAB A/S	24.11x	4.7x	15.27x	-.--%	17.44B
PHARMAESSENTIA CORPORATION	44.73x	18.1x	46.61x	0.08%	14.77B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-726.71x	34.51x	-3884.78x	-.--%	14.53B
EXELIXIS, INC.	17.37x	5.01x	11.7x	-.--%	13.84B
ARROWHEAD PHARMACEUTICALS, INC.	-26.49x	25.4x	-31.82x	-.--%	12.12B
Average	-67.82x	12.10x	-427.91x	0.2%	22.65B
Weighted average by Cap.	-36.15x	10.24x	-242.33x	0.45%